"Trust remains a critical barrier to AI success in clinical trials" was originally created and published by Clinical Trials ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.

The OCTDI under the Office of the Vice President for Health Sciences serves as a hub interconnecting interdisciplinary clinical trial research collaborations among UB investigators and our regional ...

A tailored approach with rapid needs assessment before and during implementation to address local testing site barriers in ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Governments worldwide are facing the challenge of introducing artificial intelligence (AI) ...

Artificial Intelligence (AI) can augment productivity in clinical trial delivery and more, says Piotr Maslak, Director of Operational Data Intelligence at AstraZeneca. Maslak was speaking on the first ...

The European Commission has published an updated Questions and Answers document concerning the Clinical Trials Regulation (EU) 536/2014. The document provides clarification regarding the ...

There is a growing need for vaccine trials in developing countries because some vaccines do not perform as well in developing as in industrialized country populations, and some newly developed ...

Background: Clinical trials do not represent community settings,making widespread implementation of evidence-based medicineproblematic. New heart failure treatments are an example, asresults ...